UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis

Cancer treatment reviews, 2017-04, Vol.55, p.10-15

2017

Link zum Volltext

Verfügbarkeit prüfen

Carboplatin/ nab -Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 Results

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.236-236

2017

Link zum Volltext

Verfügbarkeit prüfen

Dose-Related Effect of Statins in Venous Thrombosis Risk Reduction

Journal of vascular surgery, 2012, Vol.55 (2), p.614-615

2012

Link zum Volltext

Verfügbarkeit prüfen

EP06.01-01 Concordance Between Generative AI GPT-4 and NCCN Guidelines: Biomarker-Driven Treatment Strategies in NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S477

2023

Link zum Volltext

Verfügbarkeit prüfen

P16.01 Clonal Landscape Predicts Outcome in Lung Squamous Cell Carcinoma Patients with a Low Tumor Mutational Burden

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1015-S1015

2021

Link zum Volltext

Verfügbarkeit prüfen

P2.19-02 [DREAM] Double Lung Transplant Registry Aimed for Lung-Limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S384-S385

2023

Link zum Volltext

Verfügbarkeit prüfen

EP08.02-023 Differentiation Syndrome in a Patient with Non-Small-Cell Lung Cancer Harboring IDH2 Mutation Treated with Enasidenib

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S407-S408

2022

Link zum Volltext

Verfügbarkeit prüfen

P2.12-04 The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S152-S153

2022

Link zum Volltext

Verfügbarkeit prüfen

EP05.03-011 Bilateral Orthotopic Lung Transplantation for a Patient with Advanced Invasive Mucinous Adenocarcinoma

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S300-S301

2022

Link zum Volltext

Verfügbarkeit prüfen

P46.05 Durable Response to Double Dose Osimertinib 160mg in EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1095-S1095

2021

Link zum Volltext

Verfügbarkeit prüfen

P1.21-19 Potential Utilization of Serum Glycoproteomics as a Biomarker to Predict Survival Outcomes and irAEs in Advanced NSCLC Treated with ICI

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S242-S243

2023

Link zum Volltext

Verfügbarkeit prüfen

P1.21-18 Potential Role of Serum Glycoproteomics in Predicting irAEs in NSCLC Patients Treated with Immunotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S242

2023

Link zum Volltext

Verfügbarkeit prüfen

EP08.02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S410

2022

Link zum Volltext

Verfügbarkeit prüfen

P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S623-S624

2019

Link zum Volltext

Verfügbarkeit prüfen

255TiP [DREAM] Double lung transplant registry aimed for lung-limited malignancies: A prospective registry study for medically refractory cancers

ESMO open, 2024-03, Vol.9, p.102919, Article 102919

2024

Link zum Volltext

Verfügbarkeit prüfen

P57.11 The Role of Serum Proteomic Signature in Predicting Survival by PD-L1 Status in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1142-S1143

2021

Link zum Volltext

Verfügbarkeit prüfen

EP04.01-008 Factors Impacting Time from Biopsy to Initiation of Treatment for Advanced NSCLC at an Academic Hospital and Affiliate Hospitals

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S248-S249

2022

Link zum Volltext

Verfügbarkeit prüfen

EP04.01-007 Impact of Precision Medicine Methods on First-Line Therapies in Metastatic Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S248

2022

Link zum Volltext

Verfügbarkeit prüfen

P86.07 CDK12 Mutated Extensive Stage Small Cell Lung Cancer Showed an Exceptional Response to Olaparib and Paclitaxel

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S674-S675

2021

Link zum Volltext

Verfügbarkeit prüfen

EP07.04-10 Early-Stage EGFR Mutated NSCLC: Outcomes After Surgical Resection at a Large Academic Medical Center

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S548

2023

Link zum Volltext

Verfügbarkeit prüfen

EP06.03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S486-S487

2023

Link zum Volltext

Verfügbarkeit prüfen

P1.21-20 Tertiary Lymphoid Structures Assessed by an AI-powered Analysis of H&E Images is Correlated with Favorable Outcomes of Immunotherapy in NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S243

2023

Link zum Volltext

Verfügbarkeit prüfen

P1.27-04 Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Bronchioloalveolar Carcinoma of the Lung

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S284-S285

2023

Link zum Volltext

Verfügbarkeit prüfen

EP1.04-12 Response to Combination of Metformin and Nivolumab in a NSCLC Patient Whose Disease Previously Progressed on Nivolumab

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S976-S976

2019

Link zum Volltext

Verfügbarkeit prüfen

Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: findings from the SUMMIT basket trial

European journal of cancer (1990), 2022-10, Vol.174, p.S82-S82

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(143)
Tagungsberichte
(3)

Sprache

Englisch
(134)
Japanisch
(15)
Koreanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(42)
Humans
(18)
Physics
(17)
Biological And Medical Sciences
(14)
Physical Sciences
(13)
Animals
(10)
Biochemistry & Molecular Biology
(10)
Male
(9)
Technology
(9)
Agriculture
(8)
Female
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Medical Sciences
(8)
Agriculture, Dairy & Animal Science
(7)
Growth Performance
(7)
Microbiology
(7)
Middle Aged
(7)
Anabaena
(6)
Physics, Nuclear
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis

Carboplatin/ nab -Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 Results

Dose-Related Effect of Statins in Venous Thrombosis Risk Reduction

EP06.01-01 Concordance Between Generative AI GPT-4 and NCCN Guidelines: Biomarker-Driven Treatment Strategies in NSCLC

P16.01 Clonal Landscape Predicts Outcome in Lung Squamous Cell Carcinoma Patients with a Low Tumor Mutational Burden

P2.19-02 [DREAM] Double Lung Transplant Registry Aimed for Lung-Limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

EP08.02-023 Differentiation Syndrome in a Patient with Non-Small-Cell Lung Cancer Harboring IDH2 Mutation Treated with Enasidenib

P2.12-04 The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)

EP05.03-011 Bilateral Orthotopic Lung Transplantation for a Patient with Advanced Invasive Mucinous Adenocarcinoma

P46.05 Durable Response to Double Dose Osimertinib 160mg in EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases

P1.21-19 Potential Utilization of Serum Glycoproteomics as a Biomarker to Predict Survival Outcomes and irAEs in Advanced NSCLC Treated with ICI

P1.21-18 Potential Role of Serum Glycoproteomics in Predicting irAEs in NSCLC Patients Treated with Immunotherapy

EP08.02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study

P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

255TiP [DREAM] Double lung transplant registry aimed for lung-limited malignancies: A prospective registry study for medically refractory cancers

P57.11 The Role of Serum Proteomic Signature in Predicting Survival by PD-L1 Status in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy

EP04.01-008 Factors Impacting Time from Biopsy to Initiation of Treatment for Advanced NSCLC at an Academic Hospital and Affiliate Hospitals

EP04.01-007 Impact of Precision Medicine Methods on First-Line Therapies in Metastatic Non-Small Cell Lung Cancer

P86.07 CDK12 Mutated Extensive Stage Small Cell Lung Cancer Showed an Exceptional Response to Olaparib and Paclitaxel

EP07.04-10 Early-Stage EGFR Mutated NSCLC: Outcomes After Surgical Resection at a Large Academic Medical Center

EP06.03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center

P1.21-20 Tertiary Lymphoid Structures Assessed by an AI-powered Analysis of H&E Images is Correlated with Favorable Outcomes of Immunotherapy in NSCLC

P1.27-04 Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Bronchioloalveolar Carcinoma of the Lung

EP1.04-12 Response to Combination of Metformin and Nivolumab in a NSCLC Patient Whose Disease Previously Progressed on Nivolumab

Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: findings from the SUMMIT basket trial

Suchergebnisse filtern